Key points are not available for this paper at this time.
Scope Metabolic syndrome (MetS) significantly contributes to premature mortality, with obesity being a major risk factor. Dragon fruit, cultivated globally, exhibits bioactivity in preventing obesity‐related diseases. Traditional studies using organic solvents for extraction do not align with actual consumption patterns. Method and results This study evaluates whole red dragon fruit's effectiveness in ameliorating metabolic disorders using a high‐fat diet‐induced obesity model in mice for 20 weeks. The experimental groups include the supernatant (RS), precipitate (RP), and pomace (PO) of red dragon fruit juice, compared to the supernatant of white dragon fruit juice (WS). The study finds that dragon fruit extracts reduced adipose tissue weight, body fat percentage, pro‐inflammatory cytokines, and improved blood lipid profiles. RP is the most effective, reducing body weight by 4.33 g, improving lipid metabolism and glucose homeostasis, and altering gut microbiota to enhance beneficial bacteria and short‐chain fatty acids. RP's efficacy in preventing MetS and obesity is attributed to its bioactive components. Conclusion These findings advocate for using whole fruits in developing functional products, amplifying the agricultural economic value of red dragon fruit.
Ho et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: